Business Strategy

Lentigen's goal is to create superior shareholder value and advance human health through the successful application of its lentiviral technology to a targeted set of therapeutic and vaccine applications. Pipeline assets have been carefully selected to meet several criteria, including scientific rationale and robustness, strength of preclinical data, clinical and regulatory path, commercialization potential, market potential and unmet need. Lentigen is also pursuing other opportunities based on its broad platform technology. Lentigen's leveraging of its technology for applications other than therapeutics and vaccines will continue provide important secondary sources of funding to the operation of the company.

© Copyright 2012 Lentigen Corporation. All Rights Reserved.    + Privacy Policy    + Terms of Use